• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟药物耐药性的反教条方法:用青蒿素联合疗法重新评估治疗失败。

Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.

机构信息

Centre for Infection and Immunity, Division of Clinical Sciences, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.

出版信息

Trends Parasitol. 2013 Jul;29(7):313-7. doi: 10.1016/j.pt.2013.04.001. Epub 2013 Apr 25.

DOI:10.1016/j.pt.2013.04.001
PMID:23623760
Abstract

The definition of artemisinin resistance is becoming one of a prolonged parasite clearance phenotype, although this variable is a complex function of both host and parasite characteristics. We discuss some of the limitations of this definition of artemisinin resistance, particularly because of its potential global impact. This opinion article reviews the mechanisms underlying parasite clearance after artemisinin treatment and how these might relate to in vitro methods to assay for resistance. It revisits criteria for defining artemisinin resistance that are not currently being applied and suggests the term 'treatment failure of artemisinin combination therapy' (TFACT) as a more accurate description of most cases of 'artemisinin resistance'.

摘要

青蒿素耐药性的定义正在成为一种寄生虫清除表型的延长,尽管这种可变性是宿主和寄生虫特征的复杂函数。我们讨论了该青蒿素耐药性定义的一些局限性,特别是因为其潜在的全球影响。本文回顾了青蒿素治疗后寄生虫清除的机制,以及这些机制如何与体外检测耐药性的方法相关。它重新审视了目前未应用的青蒿素耐药性定义标准,并提出“青蒿素联合疗法治疗失败”(TFACT)一词作为大多数“青蒿素耐药性”病例的更准确描述。

相似文献

1
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.抗疟药物耐药性的反教条方法:用青蒿素联合疗法重新评估治疗失败。
Trends Parasitol. 2013 Jul;29(7):313-7. doi: 10.1016/j.pt.2013.04.001. Epub 2013 Apr 25.
2
Artemisinin resistance in Plasmodium falciparum: what is it really?疟原虫对青蒿素的抗药性:它到底是什么?
Trends Parasitol. 2013 Jul;29(7):318-20. doi: 10.1016/j.pt.2013.05.002. Epub 2013 Jun 11.
3
Artemisinin Action and Resistance in Plasmodium falciparum.青蒿素在恶性疟原虫中的作用与耐药性
Trends Parasitol. 2016 Sep;32(9):682-696. doi: 10.1016/j.pt.2016.05.010. Epub 2016 Jun 9.
4
Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.新型 pfkelch13 基因突变与印度东部的青蒿素耐药性相关。
Clin Infect Dis. 2019 Sep 13;69(7):1144-1152. doi: 10.1093/cid/ciy1038.
5
How genomics is contributing to the fight against artemisinin-resistant malaria parasites.基因组学如何助力对抗青蒿素耐药疟原虫。
Acta Trop. 2015 Aug;148:1-7. doi: 10.1016/j.actatropica.2015.04.007. Epub 2015 Apr 21.
6
Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.恶性疟原虫疟疾:青蒿素治疗后清除延迟的趋同进化轨迹。
Med Hypotheses. 2016 May;90:19-22. doi: 10.1016/j.mehy.2016.02.022. Epub 2016 Mar 4.
7
Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.青蒿素耐药性和恶性疟原虫清除的阶段依赖性。
J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.
8
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.印度东部出现对青蒿素耐药的恶性疟原虫疟疾的证据。
N Engl J Med. 2018 Nov 15;379(20):1962-1964. doi: 10.1056/NEJMc1713777.
9
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.界定青蒿素耐药恶性疟原虫的体内表型:一种建模方法。
PLoS Med. 2015 Apr 28;12(4):e1001823. doi: 10.1371/journal.pmed.1001823. eCollection 2015 Apr.
10
Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.抗药性疟原虫的斗争:青蒿素耐药性的挑战。
Clin Microbiol Infect. 2013 Oct;19(10):908-16. doi: 10.1111/1469-0691.12316. Epub 2013 Sep 3.

引用本文的文献

1
Inaccurate communication in health sciences: The case of 'partial artemisinin resistance' for the treatment of malaria.健康科学中的不准确沟通:以疟疾治疗中“部分青蒿素抗性”为例。
New Microbes New Infect. 2024 Nov 30;62:101544. doi: 10.1016/j.nmni.2024.101544. eCollection 2024 Dec.
2
genetic markers associated with drug resistance from patients with treatment failure in the Southern part of Senegal in 2017.2017年塞内加尔南部治疗失败患者中与耐药性相关的基因标记物。
Int J Mol Epidemiol Genet. 2024 Jun 15;15(3):22-30. doi: 10.62347/RWLA6562. eCollection 2024.
3
Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries.
42个非洲国家疟疾疫苗效力对疾病负担及耐药性的建模分析
Commun Med (Lond). 2023 Oct 13;3(1):144. doi: 10.1038/s43856-023-00373-y.
4
Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.青蒿素类药物对疟原虫 ATP 酶 6 的选择性抑制作用及在酵母中表达后的新型抑制剂的鉴定。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0207921. doi: 10.1128/aac.02079-21. Epub 2022 Apr 25.
5
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.恶性疟原虫对青蒿素类复方药物的抗药性:出现、机制和展望。
Int J Parasitol Drugs Drug Resist. 2021 Aug;16:102-118. doi: 10.1016/j.ijpddr.2021.05.007. Epub 2021 May 26.
6
Development and Validation of an Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.开发并验证一个决策工具,以指导优化重症恶性疟患者的静脉注射青蒿琥酯给药方案。
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02346-20.
7
Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa.青蒿素为基础的联合疗法(ACT)和耐药分子标志物:来自两个疟疾流行地区(印度和撒哈拉以南非洲)的临床研究的系统综述。
Int J Parasitol Drugs Drug Resist. 2021 Apr;15:43-56. doi: 10.1016/j.ijpddr.2020.11.006. Epub 2020 Dec 13.
8
Plasmodium berghei K13 Mutations Mediate Artemisinin Resistance That Is Reversed by Proteasome Inhibition.疟原虫伯氏疟原虫 K13 突变介导的青蒿素耐药性可被蛋白酶体抑制逆转。
mBio. 2020 Nov 10;11(6):e02312-20. doi: 10.1128/mBio.02312-20.
9
Advances in the research on the targets of anti-malaria actions of artemisinin.青蒿素抗疟作用靶点研究进展。
Pharmacol Ther. 2020 Dec;216:107697. doi: 10.1016/j.pharmthera.2020.107697. Epub 2020 Oct 6.
10
Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.在整个南亚,疟原虫 Kelch 基因突变谱及其对跟踪耐药性的影响。
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:49-58. doi: 10.1016/j.ijpddr.2019.10.001. Epub 2019 Oct 4.